Taysha Gene Therapies (TSHA) Asset Utilization Ratio (2023 - 2026)

Taysha Gene Therapies has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.01 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 79.45% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 79.45% YoY) and the FY2025 annual result came in at 0.02, down 56.35% from the prior year.
• Asset Utilization Ratio declined to 0.01 in Q1 2026 per TSHA's latest filing, from 0.02 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.09 in Q1 2024 and troughed at 0.01 in Q1 2026.
• A 4-year average of 0.05 and a median of 0.05 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2024 and 2026: Asset Utilization Ratio tumbled 41.65% in 2024, then tumbled 79.45% in 2026.
• Over 4 years, Asset Utilization Ratio stood at 0.08 in 2023, then tumbled by 41.65% to 0.05 in 2024, then slumped by 65.93% to 0.02 in 2025, then plunged by 40.39% to 0.01 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.02, and 0.02 for Q1 2026, Q4 2025, and Q3 2025 respectively.